Diagnostic Medical Systems SA
Diagnostic Medical Systems S.A. engages in the design, development, manufacture, and sale of medical imaging systems in France. It offers ADAM, in-house software suite; R and F solutions; bone densitometry; chest and bone room; mobile; c-arm; retrofit kit; and mammography equipment. The company was founded in 1979 and is headquartered in Gallargues-le-Montueux, France.
Diagnostic Medical Systems SA (ALDMS) - Total Liabilities
Latest total liabilities as of June 2025: €44.64 Million EUR
Based on the latest financial reports, Diagnostic Medical Systems SA (ALDMS) has total liabilities worth €44.64 Million EUR as of June 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Diagnostic Medical Systems SA - Total Liabilities Trend (2009–2024)
This chart illustrates how Diagnostic Medical Systems SA's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Diagnostic Medical Systems SA Competitors by Total Liabilities
The table below lists competitors of Diagnostic Medical Systems SA ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Global Consumer Public Company Limited
BK:GLOCON
|
Thailand | ฿756.34 Million |
|
Sprint Bioscience AB
ST:SPRINT
|
Sweden | Skr15.37 Million |
|
Brainzcompany Co. Ltd.
KQ:099390
|
Korea | ₩4.38 Billion |
|
Iep Invest
BR:IEP
|
Belgium | €17.15 Million |
|
Lulu's Fashion Lounge Holdings Inc
NASDAQ:LVLU
|
USA | $100.82 Million |
|
Econframe Bhd
KLSE:0227
|
Malaysia | RM78.19 Million |
|
Innodep Inc.
KQ:303530
|
Korea | ₩38.83 Billion |
|
UFO Moviez India Limited
NSE:UFO
|
India | ₹2.91 Billion |
Liability Composition Analysis (2009–2024)
This chart breaks down Diagnostic Medical Systems SA's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.16 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 3.56 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.78 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Diagnostic Medical Systems SA's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Diagnostic Medical Systems SA (2009–2024)
The table below shows the annual total liabilities of Diagnostic Medical Systems SA from 2009 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | €39.79 Million | +6.34% |
| 2023-12-31 | €37.42 Million | +4.74% |
| 2022-12-31 | €35.72 Million | +9.61% |
| 2021-12-31 | €32.59 Million | +13.37% |
| 2020-12-31 | €28.75 Million | +13.00% |
| 2019-12-31 | €25.44 Million | +34.20% |
| 2018-12-31 | €18.96 Million | +13.30% |
| 2017-12-31 | €16.73 Million | -22.93% |
| 2016-12-31 | €21.71 Million | +2.64% |
| 2015-12-31 | €21.15 Million | +21.64% |
| 2014-12-31 | €17.39 Million | +72.23% |
| 2013-12-31 | €10.10 Million | +10.05% |
| 2012-12-31 | €9.17 Million | -24.59% |
| 2011-12-31 | €12.17 Million | +16.24% |
| 2010-12-31 | €10.47 Million | +28.45% |
| 2009-12-31 | €8.15 Million | -- |